Navigation Links
The Quigley Corporation Licenses Naturally Derived Compound For Scar Improvement; License Requires Payments Totaling $1.1 Million To The Quigley Corporation Over A Five Year Period For Exclusive Ownership
Date:2/24/2009

trated that this compound showed an improvement in the visual appearance of scars in a comparative study versus a category leading OTC national brand name scar cream.

Dr Richard Rosenbloom MD, PhD, Exec VP, and COO of Quigley Pharma stated: "It is gratifying to see one of our patented and positively tested formulations come closer to benefiting the consumer and providing a return on our investment."

About The Quigley Corporation

The Quigley Corporation (Nasdaq: QGLY, http://www.Quigleyco.com) is a diversified natural health medical science company. Its Cold Remedy segment is a leading marketer and manufacturer of the COLD-EEZE(R) lozenges, clinically proven to cut the common cold nearly in half. COLD-EEZE customers include leading national wholesalers and distributors, as well as independent and chain food, drug and mass merchandise stores and pharmacies. The Quigley Corporation has wholly owned subsidiaries; Quigley Manufacturing Inc. consists of two FDA approved facilities to manufacture COLD- EEZE(R) lozenges as well as fulfill other contract manufacturing opportunities and Quigley Pharma Inc. (http://www.QuigleyPharma.com) conducts research in order to develop and commercialize a pipeline of patented botanical and naturally derived potential prescription drugs.

Forward-Looking Statements

Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and involve known and unknown risk, uncertainties and other factors that may cause the Company's actual performance or achievements to be materially different from the results, performance or achievements expressed or
'/>"/>

SOURCE Quigley Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Quigley Anti-Viral Compound QR448(a) Successfully Prevents Transmission of Infectious Bronchitis in Chickens
2. Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization
3. The Quigley Corporation Reports Third Quarter Results, Increases Investment in Pharmaceutical R&D for Diabetic Neuropathy
4. CEL-SCI Corporation Releases Letter to Shareholders
5. Chemstar Corporation Offers Comprehensive Deep Cleaning Programs to Combat Salmonella, Listeria, and E. coli in Retail Supermarkets
6. Christie Cookie Recalls Certain Lots of Peanut Butter Cookie Dough Due to Expanded Recall by Peanut Corporation of America
7. AGA Medical Corporation Launches Web-Based Stroke Education and Awareness Program Featuring Professional Football Player Tedy Bruschi
8. MannKind Corporation to Review Positive Results From Final Two Pivotal Phase 3 Clinical Studies in Type 1 and Type 2 Diabetes
9. PDS Biotechnology Corporation Progresses Development of Nanotechnology Cancer Therapies
10. Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting
11. Chemstar Corporation Announces a New Powerful, One-Step Product That Effectively Controls Listeria, Salmonella, E. coli and Fly Larvae in Floor Drains
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... 22, 2015  The Mesothelioma Victims Center is ... mesothelioma get the best possible compensation, and they are ... this rare cancer caused by exposure to asbestos ... related to treatment options such as a recent ... Mesothelioma Victims Center anytime at 866-714-6466. http://MesotheliomaVictimsCenter.Com ...
(Date:5/22/2015)... 2015 Research and Markets ( ... "Latest Regulations on Pharmaceutical International Multi-Center Clinical ... This is first time in history, ... international multi-center clinical trials of drugs in ... be implemented on March 1, 2015. The guidance ...
(Date:5/22/2015)... 2015 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX ... and commercialization of innovative therapies for the treatment of ... executive officer Howie Rosen will be presenting ... Tim Morris will be presenting at JMP ... are as follows: Jefferies 2015 Healthcare Conference ...
Breaking Medicine Technology:Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 2Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 3Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 4Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 52015 Regulations on Pharmaceutical International Multi-Center Clinical Trials in China 2AcelRx Pharmaceuticals to Present at Two Upcoming Investor Conferences In June 2
... , , NEW YORK , Jan. ... report is available in its catalogue: , Ophthalmic Pharmaceutical ... , Prevention of blindness has emerged into a ... And increased healthcare spending in these countries is creating a ...
... REDWOOD CITY, Calif. , Jan. 28 Cardica, Inc. (Nasdaq: ... and six months ended December 31, 2009 . Cardica,s management will ... discuss the financial results and provide an update on the company,s business. ... for our cardiac anastomosis products from a direct sales force to a ...
Cached Medicine Technology:Ophthalmic Pharmaceutical Drugs - A Global Market Perspective 2Ophthalmic Pharmaceutical Drugs - A Global Market Perspective 3Ophthalmic Pharmaceutical Drugs - A Global Market Perspective 4Ophthalmic Pharmaceutical Drugs - A Global Market Perspective 5Ophthalmic Pharmaceutical Drugs - A Global Market Perspective 6Ophthalmic Pharmaceutical Drugs - A Global Market Perspective 7Ophthalmic Pharmaceutical Drugs - A Global Market Perspective 8Ophthalmic Pharmaceutical Drugs - A Global Market Perspective 9Ophthalmic Pharmaceutical Drugs - A Global Market Perspective 10Ophthalmic Pharmaceutical Drugs - A Global Market Perspective 11Cardica Announces Fiscal 2010 Second Quarter Financial Results 2Cardica Announces Fiscal 2010 Second Quarter Financial Results 3Cardica Announces Fiscal 2010 Second Quarter Financial Results 4Cardica Announces Fiscal 2010 Second Quarter Financial Results 5Cardica Announces Fiscal 2010 Second Quarter Financial Results 6Cardica Announces Fiscal 2010 Second Quarter Financial Results 7Cardica Announces Fiscal 2010 Second Quarter Financial Results 8Cardica Announces Fiscal 2010 Second Quarter Financial Results 9
(Date:5/24/2015)... CA (PRWEB) May 24, 2015 ... clear indicator that the single best option for avoiding ... reveals that fitness level was the single most powerful ... for variables such as diabetes and family history of ... of maintaining lifelong heart and lung fitness. , The ...
(Date:5/23/2015)... San Diego, CA (PRWEB) May 23, 2015 ... businesses, especially small businesses, are finding it increasingly difficult ... Those businesses which fail to provide adequate insurance for ... healthcare for businesses been such an integral part of ... provide more affordable healthcare for businesses, Online USA Doctors ...
(Date:5/23/2015)... A live auction will be held to sell ... and other medical facilities around the United States. Various ... surgery, anesthesia, exam and much more. , The live ... 28 starting at 9:00am CDT each day. The equipment is ... Melrose Park, IL 60160. Anyone can participate in the ...
(Date:5/22/2015)... May 22, 2015 The world ... and capacity are intersecting to create new opportunities ... the opening speaker at WesternU's 34th annual Commencement ... Gov. Gavin Newsom, a former San Francisco mayor ... speaker at the graduation ceremony for WesternU's colleges ...
(Date:5/22/2015)... 2015 River Valley Health Partners (RVHP) ... health system’s Chief Financial Officer (CFO), will be leaving ... as the company CFO since 2011. , The Board ... the health system as CFO. Wesley will oversee the ... the Board of Trustees conducts a formal search for ...
Breaking Medicine News(10 mins):Health News:Recent Mayo Clinic Studies Help to Highlight the Value of Cardio Testing 2Health News:Recent Mayo Clinic Studies Help to Highlight the Value of Cardio Testing 3Health News:Online USA Doctors Now Offers Cost-Saving Alternative Healthcare for Businesses 2Health News:Online USA Doctors Now Offers Cost-Saving Alternative Healthcare for Businesses 3Health News:Over 5,200 Lots of Medical Equipment Will Be Sold by Live Auction 2Health News:Newsom to WesternU Grads: The Future is Inside You 2Health News:Newsom to WesternU Grads: The Future is Inside You 3Health News:River Valley Health Partners Announces CFO Transition, Appointment of Interim CFO 2
... First National Healthcare Decisions Day comes to Pennsylvania Wednesday ... ... national survey,indicates that Americans are more likely to talk with their children ... end-of-life,wishes. The same survey respondents also shared that they would want others,to ...
... Poster presentations highlight findings related to two botanical functional ... food ingredients, GLPH-1(TM) and PPL-240(TM), ... LLC, a,company that markets scientifically validated and organically derived,ingredients ... findings,from four studies that evaluate GLPH-1(TM), an immune booster, ...
... Filed in ... ... KV Pharmaceutical,Company (NYSE: KVa/KVb), a fully integrated specialty pharmaceutical,company that ... pharmaceutical,products, announced today that it has reached a comprehensive settlement,agreement ...
... say , , TUESDAY, April 8 (HealthDay News) -- Just ... the cardiac performance and breathing capacity of patients with ... more strenuous exercise program -- in standard use in ... least as well as the less intense American regimen, ...
... patients treated with high-dose chemotherapy did not have better ... to a randomized controlled trial published online April 8 ... . , SCLC accounts for nearly 13 percent of ... patients with SCLC initially respond to chemotherapy, most suffer ...
... learn by looking at the spines of hundreds of Finnish ... the Twin Spine Study, you find compelling proof that back ... physical strain. , The findings of the Twin Spine Study, ... a dramatic paradigm shift in the way disc degeneration is ...
Cached Medicine News:Health News:National Healthcare Decisions Survey: It's Easier to Talk About Drugs and Sex Than End-of-Life Planning 2Health News:Gourmetceuticals Presents Findings on Science You Can Eat at Experimental Biology 2008 2Health News:Gourmetceuticals Presents Findings on Science You Can Eat at Experimental Biology 2008 3Health News:KV Pharmaceutical Company Announces Proposed Settlement in Principle of Derivative Shareholder Litigation 2Health News:KV Pharmaceutical Company Announces Proposed Settlement in Principle of Derivative Shareholder Litigation 3Health News:A Month of Exercise Helps Ease Heart Failure 2Health News:High-intensity chemotherapy does not improve survival in small cell lung cancer 2Health News:Award-winning study says back pain may be in your genes 2
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
... The 5mm AEM Laparoscopic Instruments incorporate ... AEM Instruments are shielded and monitored to ... of the instrument caused by insulation failure ... risk. The protective shield built into all ...
Medicine Products: